John J Iii Wiesehan Net Worth

What's John Wiesehan's mailing address?

John's mailing address filed with the SEC is C/O 8845 RED OAK BLVD, , CHARLOTTE, NC, 28217.

Insiders trading at cbdMD Inc

Over the last 12 years, insiders at cbdMD Inc have traded over $2,896,358 worth of cbdMD Inc stock and bought 497,400 units worth $504,646 . The most active insiders traders include Martin A. Sumichrast, Raymond Scott Coffman et Peter J. Ghiloni. On average, cbdMD Inc executives and independent directors trade stock every 63 days with the average trade being worth of $40,364. The most recent stock trade was executed by Thomas Ronan Kennedy on 3 May 2023, trading 5,000 units of YCBD stock currently worth $10,500.

What does cbdMD Inc do?

cbdmd, inc. produces and distributes various cannabidiol (cbd) products. it owns and operates consumer hemp-based cbd brands, such as cbdmd and paw cbd. its cbdmd brand products include cdb tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. the company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the paw cbd brand name. it distributes its products through its e-commerce website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the united states. the company was formerly known as level brands, inc. and changed its name to cbdmd, inc. in may 2019. cbdmd, inc. was founded in 2015 and is headquartered in charlotte, north carolina.

cbdMD Inc executives and stock owners

cbdMD Inc executives and other stock owners filed with the SEC include:

• Martin A. Sumichrast,
  Chairman & Co-CEO
• Raymond Scott Coffman,
  Co-Founder, Pres, Co-CEO & Director
• Kevin MacDermott,
  Pres
• David Johnson,
  Sr. VP of Bus. Devel.
• Dr. Sibyl Swift Ph.D.,
  VP for Scientific & Regulatory Affairs
• Matthew Coapman,
  Chief Marketing Officer
• Dave Johnson,
  Sr. VP of Bus. Devel.
• Matt Coapman,
  Chief Marketing Officer
• Francisco Mangual,
  Sr. VP of Sales
• Robert Pettway,
  Director of PR
• Lance Blundell,
  Gen. Counsel
• John Weston,
  Director of Investor Relations
• T. Ronan Kennedy,
  CFO, COO, Sec. & Treasurer
• William F Iii Raines,
  Director
• Anthony Kennedy Shriver,
  
• Sim Farar,
  
• Seymour Siegel,
  
• Peter J. Ghiloni,
  
• Gregory C Morris,
  
• Mark S Elliott,
  
• Caryn Nicole Dunayer,
  President
• Thomas Ronan Kennedy,
  Interim CEO and CFO
• John J Iii Wiesehan,
  Chief Revenue Officer
• Martin A. Sumichrast,
  Chairman, CEO
• Kevin Mac Dermott,
  President
• Raymond Scott Coffman,
  10% owner
• Sibyl Nichole Swift,
  Director
• Bakari T. Sellers,
  Director
• Scott G. Stephen,
  Director